1-20 of 106
Patrick B. Johnston
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PET2 Response Associated with Survival in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Results of Two Independent Prospective Cohorts

Sanjal H Desai, Levi D. Pederson, Betsy Laplant, Raphael Mwangi, Matthew J. Maurer, Jason R. Young, William R. Macon, Rebecca L. King, Yucai Wang, James R. Cerhan, Andrew L. Feldman, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski
Journal: Blood
Blood (2021) 138 (Supplement 1): 2508.
DOI: https://doi.org/10.1182/blood-2021-151276
Published: 2021
Journal Articles

Metabolic PET/CT Analysis of Aggressive Non-Hodgkin Lymphoma Prior to Axicabtagene Ciloleucel CAR-T Infusion: Predictors of Progressive Disease, Survival, and Toxicity

William Breen, Jason R. Young, Matthew Hathcock, Roman O. Kowalchuk, Radhika Bansal, Arushi Khurana, N. Nora Bennani, Jonas Paludo, Jose C. Villasboas, Yucai Wang, Stephen M. Ansell, Jennifer Peterson, Patrick B. Johnston, Scott Lester, Yi Lin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2518.
DOI: https://doi.org/10.1182/blood-2021-153739
Published: 2021
Journal Articles

Barriers to Enrollment in Clinical Trials in Patients with Aggressive B-Cell Non-Hodgkin Lymphoma That Progressed after Anti-CD19 CART Cell Therapy

Evandro D. Bezerra, Javier Munoz, Hemant S. Murthy, Arushi Khurana, Radhika Bansal, Madiha Iqbal, Matthew J. Maurer, Matthew A Hathcock, Patrick B. Johnston, Nora Bennani, Jonas Paludo, Yucai Wang, Jose C. Villasboas, Allison C. Rosenthal, Stephen M. Ansell, Thomas E. Witzig, Januario E Castro, Mohamed A. Kharfan-Dabaja, Grzegorz S. Nowakowski, Yi Lin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2527.
DOI: https://doi.org/10.1182/blood-2021-146119
Published: 2021
Journal Articles

Immunologic Autograft Engineering: 13 Years Follow-up

Luis F. Porrata, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Jose C. Villasboas, Jonas Paludo, Svetomir N. Markovic
Journal: Blood
Blood (2021) 138 (Supplement 1): 3936.
DOI: https://doi.org/10.1182/blood-2021-148454
Published: 2021
Journal Articles

Lisocabtagene Maraleucel (liso-cel), a CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy, Versus Standard of Care (SOC) with Salvage Chemotherapy (CT) Followed By Autologous Stem Cell Transplantation (ASCT) As Second-Line (2L) Treatment in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Randomized Phase 3 Transform Study

Manali Kamdar, Scott R. Solomon, Jon E. Arnason, Patrick B. Johnston, Bertram Glass, Veronika Bachanova, Sami Ibrahimi, Stephan Mielke, Pim G.N.J. Mutsaers, Francisco J. Hernandez-Ilizaliturri, Koji Izutsu, Franck Morschhauser, Matthew A. Lunning, David G. Maloney, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, Lara Stepan, Ken Ogasawara, Timothy Mack, Jeremy S. Abramson
Journal: Blood
Blood (2021) 138 (Supplement 1): 91.
DOI: https://doi.org/10.1182/blood-2021-147913
Published: 2021
Journal Articles

Autograft-Absolute Lymphocyte Count Infusion Predicts Survival in Double/Triple Hit Lymphomas Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation

Luis F. Porrata, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Jose Villasboas, Jonas Paludo, Svetomir N. Markovic
Journal: Blood
Blood (2021) 138 (Supplement 1): 1836.
DOI: https://doi.org/10.1182/blood-2021-144345
Published: 2021
Journal Articles

Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma

Julia E. Wiedmeier, Madiha Iqbal, Javier Munoz, Evandro D. Bezerra, Juan Esteban Garcia Robledo, Radhika Bansal, Patrick B. Johnston, Matthew Hathcock, Jeremy T. Larsen, P. Leif Bergsagel, Yucai Wang, Craig B. Reeder, Jose F. Leis, Rafael Fonseca, Jeanne M. Palmer, Rahma M Warsame, Taxiarchis Kourelis, Suzanne R. Hayman, David Dingli, Prashant Kapoor, Shaji Kumar, Urshila Durani, Jose C. Villasboas, Jonas Paludo, N. Nora Bennani, Stephen M. Ansell, Januario E Castro, Mohamed A. Kharfan-Dabaja, Yi Lin, Paschalis Vergidis, Hemant S. Murthy, Allison C. Rosenthal
Journal: Blood
Blood (2021) 138 (Supplement 1): 1750.
DOI: https://doi.org/10.1182/blood-2021-151859
Published: 2021
Journal Articles

Characteristics, Management and Outcomes of Patients with Intravascular Lymphoma: A Mayo Clinic Experience

Karan Seegobin, Muhamad Alhaj Moustafa, Umair Majeed, Liuyan Jiang, David Menke, Ke Li, Mohamed A. Kharfan-Dabaja, Ernesto Ayala, Madiha Iqbal, Grzegorz S. Nowakowski, Thomas M. Habermann, Thomas E. Witzig, Patrick B. Johnston, Carrie A. Thompson, Stephen M. Ansell, Han W. Tun
Journal: Blood
Blood (2021) 138 (Supplement 1): 1452.
DOI: https://doi.org/10.1182/blood-2021-146408
Published: 2021
Journal Articles

Response to Bridging Therapy As a Predictor of Outcomes for Chimeric Antigen Receptor Therapy in Large B-Cell Lymphoma

Arushi Khurana, Matthew Hathcock, Radhika Bansal, Yucai Wang, Jonas Paludo, Jose C. Villasboas, N. Nora Bennani, Patrick B. Johnston, Stephen M. Ansell, Yi Lin
Journal: Blood
Blood (2021) 138 (Supplement 1): 3841.
DOI: https://doi.org/10.1182/blood-2021-154186
Published: 2021
Journal Articles

Polatuzumab Vedotin Use before Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Aggressive Lymphoma: A US Single Center Experience

Arushi Khurana, Radhika Bansal, Matthew Hathcock, Adrienne Nedved, Yucai Wang, Jonas Paludo, Jose C Villasboas, N. Nora Bennani, Patrick B. Johnston, Stephen M. Ansell, Yi Lin
Journal: Blood
Blood (2021) 138 (Supplement 1): 3842.
DOI: https://doi.org/10.1182/blood-2021-152313
Published: 2021
Journal Articles

Improved Quality of Life (QOL) with Lisocabtagene Maraleucel (liso-cel), a CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy, Compared with Standard of Care (SOC) As Second-Line (2L) Treatment in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma ( LBCL): Results from the Phase 3 Transform Study

Jeremy S. Abramson, Scott R. Solomon, Jon E. Arnason, Patrick B. Johnston, Bertram Glass, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, Fei Fei Liu, Julia Braverman, Shien Guo, Ling Shi, Manali Kamdar
Journal: Blood
Blood (2021) 138 (Supplement 1): 3845.
DOI: https://doi.org/10.1182/blood-2021-151611
Published: 2021
Journal Articles

Peak Absolute Lymphocyte Count Post CAR-T Is Associated with Clinical Response and Survival Outcome in Aggressive Lymphoma

Radhika Bansal, Anatilde Gonzalez Guerrico, Henan Zhang, Zuoyi Shao, Elham Babadi, Kodi E Marinez, Gabrielle Gonzalez McCoy, Matthew A Hathcock, Arushi Khurana, N. Nora Bennani, Jonas Paludo, Yucai Wang, Stephen M. Ansell, Patrick B. Johnston, Jose C Villasboas, Yi Lin
Journal: Blood
Blood (2021) 138 (Supplement 1): 3856.
DOI: https://doi.org/10.1182/blood-2021-151295
Published: 2021
Journal Articles

Vaccine Titers in Lymphoma Patients Receiving Chimeric Antigen Receptor T Cell Therapy

Radhika Bansal, Paschalis Vergidis, Pritish K Tosh, John Wilson, Matthew Hathcock, Arushi Khurana, N. Nora Bennani, Jonas Paludo, Jose C. Villasboas, Yucai Wang, Stephen M. Ansell, Patrick B. Johnston, Catherine Freeman, Yi Lin
Journal: Blood
Blood (2021) 138 (Supplement 1): 3857.
DOI: https://doi.org/10.1182/blood-2021-153500
Published: 2021
Journal Articles

Pilot Implementation of Remote Patient Monitoring Program for Outpatient Management of CAR-T Cell Therapy

Jonas Paludo, Radhika Bansal, Adam T Holland, Kelsey L Haugen, Megan T Spychalla, Alli L McClanahan, Tuan A Truong, Matthew A Hathcock, Arushi Khurana, Hassan B. Alkhateeb, David Dingli, Suzanne R. Hayman, Prashant Kapoor, Morie A. Gertz, Yucai Wang, Saad S. Kenderian, Taxiarchis Kourelis, Shaji Kumar, Mithun V. Shah, Mustaqeem A. Siddiqui, Rahma M Warsame, Jose C. Villasboas, Nora Bennani, Patrick B. Johnston, Stephen M. Ansell, Tufia C Haddad, Yi Lin
Journal: Blood
Blood (2021) 138 (Supplement 1): 568.
DOI: https://doi.org/10.1182/blood-2021-149103
Published: 2021
Journal Articles

Central Nervous System Involvement By Mantle Cell Lymphoma

Nicole McLaughlin, Jonas Paludo, Yucai Wang, David J. Inwards, Nora Bennani, Gita Thanarajasingam, Jose C. Villasboas, Grzegorz S. Nowakowski, Luis F. Porrata, Carrie A. Thompson, Ivana N. Micallef, Patrick B. Johnston, Thomas E. Witzig, Thomas M. Habermann, Stephen M. Ansell
Journal: Blood
Blood (2021) 138 (Supplement 1): 2426.
DOI: https://doi.org/10.1182/blood-2021-148447
Published: 2021
Journal Articles

Parsaclisib in Combination with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: Preliminary Results of a Phase 1/1b Study

Yucai Wang, Betsy Laplant, Rebecca L. King, Ivana N. Micallef, Stephen M. Ansell, Han W. Tun, Madiha Iqbal, Gita Thanarajasingam, Allison C. Rosenthal, David J. Inwards, Patrick B. Johnston, Luis F. Porrata, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski
Journal: Blood
Blood (2021) 138 (Supplement 1): 1415.
DOI: https://doi.org/10.1182/blood-2021-147507
Published: 2021
Journal Articles

Impact of Novel Agents on the Outcomes of Patients with Classic Hodgkin Lymphoma That Relapsed after Autologous Stem Cell Transplant

Aung M Tun, Yucai Wang, Aasiya Matin, David J. Inwards, Patrick B. Johnston, Ivana N. Micallef, Luis F. Porrata, Jose C. Villasboas, Jonas Paludo, Han W. Tun, Allison C. Rosenthal, James R. Cerhan, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski, Stephen M. Ansell
Journal: Blood
Blood (2021) 138 (Supplement 1): 1373.
DOI: https://doi.org/10.1182/blood-2021-154038
Published: 2021
Journal Articles

Improvement in Outcomes of Autologous Stem Cell Transplant in Patients with Lymphoma Older Than 70 Years: The Significance of Age in 2020s?

Kitsada Wudhikarn, Bradley K. Johnson, Jose C. Villasboas, Jonas Paludo, David J. Inwards, Luis F. Porrata, Ivana N. Micallef, Stephen M. Ansell, Patrick B. Johnston
Journal: Blood
Blood (2021) 138 (Supplement 1): 2908.
DOI: https://doi.org/10.1182/blood-2021-144507
Published: 2021
Journal Articles

Impact of Cell of Origin (COO) on Long Term Outcomes Post Autologous Hematopoietic Cell Transplant in Patients with Relapsed/ Refractory Chemotherapy Sensitive De-Novo Diffuse Large B-Cell Lymphoma (DLBCL)

Madiha Iqbal, MBBS, Yennifer Gil, Jonas Paludo, MD, Allison C. Rosenthal, D.O., Zhou Li, MS, Manuel Beltran, David J. Inwards, MD, Luis F. Porrata, MD, Ivana Micallef, MD, Jose C Villasboas, MD, Patrick B. Johnston, Stephen M. Ansell, MD PhD, Craig B. Reeder, MD, Hemant S. Murthy, MD, Vivek Roy, MD, James M. Foran, MD, Han W. Tun, MD, Mohamed A. Kharfan-Dabaja, MDMBA, Ernesto Ayala, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
DOI: https://doi.org/10.1182/blood-2020-136332
Published: 2020
Journal Articles

Consolidation with Nivolumab and Brentuximab Vedotin after Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma

Alex F. Herrera, MD, Lu Chen, PhD, Yago Nieto, MD, Leona Holmberg, MD PhD, Patrick B. Johnston, Matthew Mei, MD, Leslie Popplewell, MD, Saro H. Armenian, DO, MPH, Thai Cao, MD, Len Farol, MD, Firoozeh Sahebi, MD, Ricardo Spielberger, MD, Robert Chen, MD, Auayporn P. Nademanee, MDBS, Lacolle Peters, Neena Kennedy, Steven T. Rosen, MD, Larry W Kwak, MD PhD, Stephen J. Forman, MD, Tatyana A. Feldman, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
DOI: https://doi.org/10.1182/blood-2020-136384
Published: 2020